Department of Neurosurgery, The Ohio State University Medical Center and The James Cancer Center, Columbus, OH, USA.
Spine (Phila Pa 1976). 2009 Oct 15;34(22 Suppl):S93-100. doi: 10.1097/BRS.0b013e3181b77895.
Systematic review of the literature.
Should cement augmentation procedures such as vertebroplasty and kyphoplasty be used in patients with painful compression fractures associated with metastatic spine disease? What is the role of embolization in the treatment of metastatic spine disease?
Vertebral augmentation is commonly employed in treating osteoporotic fractures and is now increasingly used in the management of pain in patients with spinal tumors. Intra-arterial and transcutaneous embolization techniques are also available in the management of spinal tumors. To date, the effectiveness and safety of these procedures have not been adequately demonstrated.
A review of the English literature was performed in Pub-Med. One search was performed using the following keywords: cancer, tumor, vertebroplasty, kyphoplasty, vertebral augmentation, outcome, safety, pain, and quality of life. A Second search was performed using the keywords: embolization, spinal, and tumors. Original studies reporting on at least 10 patients were included and systematically reviewed. The results were reviewed and discussed through consensus among a multidisciplinary panel of expert members of the Spine Oncology Study Group. Recommendations were made according to the Guyatt Guidelines.
A total of 1665 abstracts were identified. Twenty-eight articles using vertebroplasty reported on 877 patients and 1599 treated levels. Medical and neurologic complications varied from 0% to 7.1% and 0% to 8.1%, respectively. Twelve articles using kyphoplasty reported on 333 patients and 481 treated levels. Medical complication rates varied from 0% to 0.5%, without any neurologic complications. Pain and functional outcomes were universally successful using either technique. Ten studies on embolization reported on 330 patients. There were 4 permanent complications (1.4%). Complete or partial embolization was possible in 97.5% with an estimated reduction of intraoperative blood loss of 2.3 L.
There is strong recommendation and moderate evidence for vertebral augmentation as safe and effective in providing pain relief and improving functional outcome in patients with vertebral body fractures and axial pain due to metastatic disease. There is a strong recommendation and very low evidence for embolization techniques as safe and effective in decreasing intraoperative blood loss in hypervascular tumors.
文献系统回顾。
在伴有转移性脊柱疾病的疼痛性压缩骨折患者中,是否应使用骨水泥增强术(如椎体成形术和后凸成形术)?栓塞在治疗转移性脊柱疾病中的作用是什么?
椎体增强术常用于治疗骨质疏松性骨折,现在越来越多地用于治疗脊柱肿瘤患者的疼痛。动脉内和经皮栓塞技术也可用于治疗脊柱肿瘤。迄今为止,这些手术的有效性和安全性尚未得到充分证明。
在 Pub-Med 上进行了英语文献的回顾。使用以下关键字进行了一次搜索:癌症、肿瘤、椎体成形术、后凸成形术、椎体增强、结果、安全性、疼痛和生活质量。使用关键字进行了第二次搜索:栓塞、脊柱和肿瘤。纳入了至少报告了 10 例患者的原始研究,并进行了系统回顾。通过脊柱肿瘤研究组多学科专家小组的共识,对结果进行了审查和讨论。根据 Guyatt 指南提出了建议。
共确定了 1665 篇摘要。28 篇使用椎体成形术的文章报告了 877 例患者和 1599 个治疗节段。医疗和神经系统并发症分别为 0%至 7.1%和 0%至 8.1%。12 篇使用后凸成形术的文章报告了 333 例患者和 481 个治疗节段。医疗并发症发生率为 0%至 0.5%,无神经系统并发症。两种技术的疼痛和功能结果均普遍成功。10 项关于栓塞的研究报告了 330 例患者。有 4 例永久性并发症(1.4%)。97.5%的患者可实现完全或部分栓塞,估计术中失血量减少 2.3 升。
有强烈的推荐和中等证据表明,椎体增强术在缓解疼痛和改善因转移性疾病引起的椎体骨折和轴向疼痛的功能结果方面是安全有效的。有强烈的推荐和极低的证据表明,栓塞技术在减少高血运肿瘤的术中失血量方面是安全有效的。